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Abstract
The C. elegans eat-6 gene encodes a Na
+,K
+-ATPase a subunit and is a homolog of the familial hemiplegic migraine
candidate gene FHM2. Migraine is the most common neurological disorder linked to serotonergic dysfunction. We sought
to study the pathophysiological mechanisms of migraine and their relation to serotonin (5-HT) signaling using C. elegans as
a genetic model. In C. elegans, exogenous 5-HT inhibits paralysis induced by the acetylcholinesterase inhibitor aldicarb. We
found that the eat-6(ad467) mutation or RNAi of eat-6 increases aldicarb sensitivity and causes complete resistance to 5-HT
treatment, indicating that EAT-6 is a component of the pathway that couples 5-HT signaling and ACh neurotransmission.
While a postsynaptic role of EAT-6 at the bodywall NMJs has been well established, we found that EAT-6 may in addition
regulate presynaptic ACh neurotransmission. We show that eat-6 is expressed in ventral cord ACh motor neurons, and that
cell-specific RNAi of eat-6 in the ACh neurons leads to hypersensitivity to aldicarb. Electron microscopy showed an increased
number of synaptic vesicles in the ACh neurons in the eat-6(ad467) mutant. Genetic analyses suggest that EAT-6 interacts
with EGL-30 Gaq, EGL-8 phospholipase C and SLO-1 BK channel signaling to modulate ACh neurotransmission and that
either reduced or excessive EAT-6 function may lead to increased ACh neurotransmission. Study of the interaction between
eat-6 and 5-HT receptors revealed both stimulatory and inhibitory 5-HT inputs to the NMJs. We show that the inhibitory and
stimulatory 5-HT signals arise from distinct 5-HT neurons. The role of eat-6 in modulation of excitatory neurotransmission by
5-HT may provide a genetic explanation for the therapeutic effects of the drugs targeting 5-HT receptors in the treatment of
migraine patients.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) functions as a neuro-
modulator by inhibiting and enhancing synaptic transmission of
other neurotransmitters. Dysregulation of 5-HT signaling has been
implicated in pathophysiology of many disorders, including
migraine [1]. Migraine is a polygenic trait. Familial hemiplegic
migraine (FHM) is a rare autosomal dominant subtype of migraine
associated with genetic lesions in three genes, FHM1 encoding the
a1 subunit of the voltage-gated Ca
2+ channel CACNA1A, FHM2
encoding the a2 subunit of the Na
+,K
+-ATPase ATP1A2, and
FHM3 encoding the a1 subunit of the voltage-gated Na
+ channel
SCN1A [2]. According to the current view, mutations in these
genes result in excessive excitatory neurotransmission in the brain
leading to migraine pain [3]. However, verification of this
hypothesis, as well as analysis of the relationship between migraine
and 5-HT signaling is difficult due to the complexity of
mammalian nervous systems. The nematode C. elegans is an
attractive genetic model to study neuronal functions in vivo. The
first two FHM genes are conserved in this organism and are
designated as unc-2 and eat-6, respectively. Analysis of unc-2
mutants has been undertaken for modeling of FHM1 migraine
channelopathy [4]. In this study, we focused on the FHM2
homolog eat-6 to gain new insights into biochemical and
physiological mechanisms of migraine pathology.
The Na
+,K
+-ATPase is a sodium pump that uses energy derived
from ATP hydrolysis to extrude cytoplasmic Na
+ in exchange for
extracellular K
+ across the plasma membrane [5]. In human there
are four genes encoding Na
+,K
+-ATPase a subunits [6]. The a1
isoform is the ubiquitous housekeeping enzyme. FHM2 is the a2
isoform, which together with the a3 isoform is enriched in neuronal
andmuscular systems, and the a4 isoform isconfined to testis. Inthe
adult brain a2 is mostly expressed in glia; besides, it is present in
skeletal muscle, heart and other tissues. The C. elegans genome
harbors four other Na
+,K
+-ATPase a subunit genes besides eat-6
[7]. EAT-6 appears to be the closest functional homolog of FHM2,
as no other a subunit genes are expressed in excitable cells [8].
EAT-6 and FHM2 share 72% identity, 84% homology at the
protein level. A homozygous eat-6 deletion mutant is reported to be
embryonic lethal/early larval arrest (http://www.wormbase.org).
Four other eat-6 mutations were initially isolated for feeble
contractions and delayed relaxations of the pharyngeal muscles
[9], and subsequently shown to affect the membrane potential of
these cells[10].A recent studydemonstrated that eat-6is localizedat
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[8]. Taken together, these studies convinced us that further research
into eat-6 function in C. elegans might provide a deeper insight into
the mechanisms of migraine in humans.
Here we provide evidence that eat-6 may also act in locomotory
cholinergic neurons, and that mutations in eat-6 disrupt inhibitory
5-HT input to the control of excitatory synaptic transmission at C.
elegans bodywall NMJs.
Results
Molecular lesions of eat-6 alleles
Sequencing of mutant genomic DNA confirmed that ad467,
ad601 and ad997 alleles are missense mutations leading to the
following amino acid substitutions in the EAT-6 protein: L359F,
G522E and S761F, respectively [11]. In addition, we identified
that the ad792 allele carries a missense mutation that results in the
R569H substitution. All four eat-6 mutations substitute amino acid
residues that are conserved in human FHM2. Three out of four
mutated residues are in the intracellular 4–5 loop (Figure 1), which
contains the nucleotide-binding domain and the phosphorylation
site essential for the enzymatic activity [5,12]. The majority of
mutations found in human migraine patients are also located in
this region [13]. The sites of the ad467 and ad601 mutations are
very close to the sites of pathological human mutations, and the
ad792 mutation substitutes the same residue as the FHM2(R593W)
mutation [14].
eat-6(ad467) mutant is hypersensitive to aldicarb and
does not respond to 5-HT
Aldicarb, an inhibitor of acetylcholinesterase, causes paralysis in
C. elegans due to accumulation of acetylcholine (ACh) at the
locomotory NMJs, and is therefore frequently used to measure the
steady state ACh release in living C. elegans animals [15,16]. In WT
animals exogenous 5-HT slowed down the paralytic effect of
aldicarb (Figure 2a). By contrast, 5-HT treatments did not reduce
the sensitivity to paralysis induced by levamisole, a specific agonist
of the nicotinic ACh receptor UNC-29 in the bodywall muscles
(data not shown) [17]. These results suggest that 5-HT signaling
inhibits ACh release by the motor neurons [17]. Out of four tested
eat-6 alleles, the ad467 mutant showed the strongest defects in the
function of the pharyngeal muscles [10]; we found that ad467
animals were hypersensitive to aldicarb and completely resistant to
5-HT treatment (Figure 2b,c). The ad997 and ad792 mutations
that modestly disrupted the function of the pharyngeal muscles
[10] did not cause significant hypersensitivity to aldicarb, although
the ad997 mutation reduced the response to 5-HT treatment
(Figure 2c). Interestingly, the ad601 mutation that least affected the
function of the pharyngeal muscles [10] caused the strongest
hypersensitivity to aldicarb (Figure 2c) [8].
To further characterize the effect of eat-6 mutations on
sensitivity to 5-HT, we tested the egg-laying response of the
mutants to 5-HT treatment. In WT animals, exogenous 5-HT
stimulated egg laying (Figure 2d) [18]. The ad467 mutant laid
practically no eggs in response to 5-HT, whereas all the other
three eat-6 alleles laid some (Figure 2d, hatched bars). To exclude
the possibility that the failure of ad467 animals to lay eggs in
response to 5-HT was simply due to a reduced number of fertilized
eggs, we counted the number of eggs in the uterus of one-day old
adult hermaphrodite worms. Although all four eat-6 alleles had
reduced number of eggs in the uterus, ad467 worms carried at least
as many fertilized eggs as ad792 and ad997 mutants (Figure 2d,
black bars). Therefore, we concluded that the eat-6(ad467)
mutation disrupts 5-HT regulation in the egg-laying circuit as
Figure 1. Predicted topology of EAT-6/FHM2 and location of mutations. A schematic depiction of the human FHM2 protein generated by
the TOPO2 program (http://www.sacs.ucsf.edu/TOPO2). The sites of mutations found in migraine patients [13] are shown by black circles.
Corresponding residues of eat-6 mutations are shown by black triangles.
doi:10.1371/journal.pone.0010368.g001
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the bodywall NMJs. The differential effects of the eat-6 mutations
on the function of the pharyngeal muscles [10], the sensitivity to
aldicarb and the responses to 5-HT suggest allele-specific
modification of EAT-6 function in particular cellular mechanisms,
rather than a simple reduction of its activity.
Both reduction and excess of EAT-6 protein cause
hypersensitivity to aldicarb and resistance to 5-HT
To further investigate the relationship between EAT-6 function
and phenotypes seen in eat-6 mutants, we used RNA interference
(RNAi) to knock down eat-6 gene activity. The strain rrf-3(pk1426)
has enhanced neuronal sensitivity to RNAi [19]. The rrf-3 worms
fed with E. coli expressing dsRNA targeted to eat-6, but not the
empty vector (mock RNAi), showed abnormalities similar to, but
stronger than those seen in the eat-6 mutants. They had a smaller
body size, a reduced number of eggs in the uterus, hypersensitivity
to aldicarb and resistance to 5-HT (data not shown; Figure 3a),
indicating that a reduction of EAT-6 function brings about all
these phenotypes.
We next sought to rescue eat-6 mutant phenotypes by a WT eat-
6 transgene, Ex[eat-6(+)]. As it has been shown previously [10], this
transgene rescued the pharyngeal defects of the ad467 mutant
(Figure 3b,e). However, we found that the same transgenic animals
remained hypersensitive to aldicarb and resistant to 5-HT
(Figure 3a). One possible reason for this could be less efficient
expression of the eat-6 transgene in the locomotory system. But,
when we crossed this transgene into WT background, we observed
an increased sensitivity to aldicarb in the transgenic animals
compared to WT animals (Figure 3a). This result suggests that
overexpression of eat-6 may also perturb ACh synaptic transmis-
sion at the locomotory NMJs.
Extrachromosomal arrays usually carry multiple copies of the
transgene, so to test whether the aldicarb hypersensitivity of the
eat-6 mutant can be corrected by a single copy of the WT gene, we
took advantage of the nT1 genetic balancer, in which part of the
chromosome V carrying the eat-6 locus is translocated to the
chromosome IV [20]. The homozygous eat(ad467) mutant
carrying a single copy of the nT1 balancer contains two copies
of the eat-6(ad467) mutant gene and one copy of the WT eat-6 gene
from the balancer; these animals showed significantly reduced
aldicarb hypersensitivity, compared to the eat(ad467) mutant
without the balancer (Figure S1). This result is consistent with
the idea that eat-6(ad467) is a reduction-of-function mutation [10]
and suggests that a low dosage of the WT gene, in contrast to a
high dosage introduced by an extrachromosomal array, can
correct aldicarb sensitivity of the ad467 mutant.
We also characterized pharyngeal electrical activity in animals
with excess or reduced EAT-6. In contrast to the effect on aldicarb
sensitivity, expression of Ex[eat-6(+)] in WT background did not
change EPG (Figure 3b,f), which again points to distinctive functions
of EAT-6 in the pharyngeal and locomotory circuits. Furthermore,
eat-6 RNAi altered EPG differently from that seen in eat-6 mutants.
In WT and mock-treated rrf-3 control animals almost every
excitatory postsynapticpotential (EPSP)triggered an action potential
(AP) in the pharyngeal muscles (Figure 3b,c,h) [21]. Even the strong
eat-6(ad467) mutation did not change the probability of AP
generation, but reduced the rate of AP decay, which corresponds
Figure 2. eat-6(ad467) is hypersensitive to aldicarb and resistant to 5-HT. (a) and (b) The time course of aldicarb-induced paralysis of animals
pretreated with 5 mg/ml 5-HT (black circles) and without 5-HT treatment (open squares) in wild type (a) and eat-6(ad467) animals (b). The error bars
indicate SEM (n.3 replicates). T50 is the time course when 50% of the worms were paralyzed. We use reciprocal T50 values as a measurement for the
rate of paralysis. (c) Relative reciprocal T50 values of aldicarb-induced paralysis of worms pretreated with 5-HT (hatched bars) and those without 5-HT
treatment (black bars). The values of 5-HT-treated WT worms and mutants are normalized to that of WT worms without 5-HT treatment. The error
bars indicate SEM (n.3 replicates). ad467 and ad601 were hypersensitive to aldicarb compared to WT (* p,0.05, ** p,0.001). 5-HT treatment
significantly reduced the rate of aldicarb-induced paralysis in WT and ad792 animals, compared to their untreated siblings (p,0.0005), whereas no
significant reduction by 5-HT treatment was found in the ad467, ad601 and ad997 alleles. Student’s t-test. (d) Influence of 5-HT on egg laying in eat-6
mutant alleles. The bars show the number of eggs in the uterus (black bars), and the number of eggs laid per h per animal incubated in M9 buffer
(open bars) and in M9 buffer supplemented with 5 mg/ml 5-HT (hatched bars). C. elegans generally does not lay eggs in M9 [18]. The error bars
indicate SEM (n.3 replicates, 8 animals of each genotype for each condition per trial).
doi:10.1371/journal.pone.0010368.g002
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[10]. In contrast, in eat-6 RNAi worms about 50% of EPSPs failed to
elicit APs in the pharyngeal muscles (Figure 3b,g). When APs were
generated in eat-6 RNAi worms, their R peaks were not reduced
(Figure 3b,g). In fact, the mean relative amplitude of the R peak in
the eat-6 RNAi animals was even larger than that in WT and mock-
treated control (Figure 3b). Outside of the pharynx, some effects of
eat-6 mutations and eat-6 RNAi also differ. For example, the mutant
worms showed no apparent motility defects [10], whereas RNAi
animals were severely uncoordinated. These observations suggest
that the phenotypes caused by the ad467 mutation reflect allelic-
specific defects. It is possible that the mutation alters specific enzyme
properties, such as affinities for K
+ and Na
+ or voltage dependence,
as shown for several mutations in mammalian homologs of eat-6
[22,23]. However, it remains possible that some differences between
the phenotypes of ad467 worms and that of RNAi-treated animals
are due to resistance of some neurons to RNAi even in the rrf-3
background.
Cell-specific RNAi of eat-6 in ACh neurons causes
hypersensitivity to aldicarb
As the first step to determine cellular sites of EAT-6 function in
ACh signaling, we constructed a GFP reporter under the control
of the eat-6 promoter (peat-6::gfp) and generated multiple transgenic
lines from independent injections of this construct. Like that of
many other GFP reporters, the expression of peat-6::gfp was
mosaic, but was consistent in terms of cell types in at least three
lines that were carefully examined in several generations. In
agreement with a previous study [8], we observed GFP
fluorescence in the pharyngeal, bodywall and vulval muscles. In
addition, we found eat-6 expression in many neurons, including the
ventral cord ACh neurons, as well as in several head and tail
neurons (Figure 4). This expression pattern raised the possibility
that eat-6 may regulate neurotransmission both pre- and
postsynaptically.
EAT-6 function at the postsynaptic site of ACh neurotransmis-
sion at the bodywall NMJs has been reported by others [8]. In
agreement with the report [8], we observed that eat-6(ad467)
mutant animals were hypersensitive to paralysis induced by
levamisole, a specific agonist of the nicotinic ACh receptor
UNC-29 (Figure 5a). Furthermore, like the Ex[eat-6(+)] transgene,
a transgene expressing the WT eat-6 cDNA under the bodywall
muscle-specific myo-3 promoter (Muscle::eat-6) also caused strong
hypersensitivity to levamisole in the WT background (Figure 5).
This result was unexpected, as Doi and Iwasaki reported successful
rescue of the levamisole hypersensitivity of the eat-6(ad467) and eat-
Figure 3. Phenotypic analysis of eat-6 RNAi and overexpression. (a) Relative reciprocal T50 values of aldicarb-induced paralysis of animals
untreated (black bars) or pretreated with 5-HT (hatched bars). The error bars indicate SEM (n.3 replicates). Both RNAi and overexpression of eat-6
conferred hypersensitivity to aldicarb compared to WT (* p,0.05, ** p,0.01). Pretreatment of 5-HT reduced aldicarb sensitivity in WT animals
(p,0.005), but not in eat-6 RNAi animals. Student’s t-test. (b) The ratio of the amplitude of the excitation and recovery peaks (black bars, left axis), and
the fraction of EPSPs that failed to trigger APs (hatched bars, right axis). The error bars indicate SEM (n=15). (c–h) Representative EPG recordings.
EPSP designates an excitatory postsynaptic potential, E designates the peak corresponding to the muscle excitation (depolarization), R designates the
peak corresponding to muscle recovery.
doi:10.1371/journal.pone.0010368.g003
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reason for the difference is not clear, one possible explanation
could be dosage differences of eat-6 in the transgenic arrays.
We went on to test whether eat-6 also functions in the ACh
neurons to regulate neurotransmission. We knocked down eat-6
expression in the ACh neurons using cell-specific RNAi [24]. Both
transgenic lines in which eat-6 was silenced in the ACh neurons
were hypersensitive to aldicarb, but not to levamisole (Figure 5a,b).
These results suggest that, in addition to its role in the bodywall
muscles, EAT-6 in the ACh neurons may also influence ACh
neurotransmission.
Next, we expressed the eat-6 cDNA under the control of the
promoter of the vesicular ACh transporter gene unc-17 (ACh::eat-6).
Like Ex[eat-6(+)] and Muscle::eat-6, ACh::eat-6 did not correct
aldicarb hypersensitivity or 5-HT resistance in eat-6 mutant
animals (Figure S2). However, four transgenic lines expressing
ACh::eat-6 in the WT background all showed strong hypersensi-
tivity to aldicarb, but not to levamisole (Figure 5a,b). The unc-
17(e245) mutant significantly reduces ACh release, and therefore is
resistant to aldicarb-induced paralysis [25,26]. When the ACh::eat-
6 transgene was crossed into the unc-17(e245) background, the
transgenic animals became completely resistant to aldicarb (Figure
S3). These results are consistent with the model that EAT-6
functions in both the bodywall muscles and the ACh neurons, and
that either increased or decreased EAT-6 function may perturb
ACh neurotransmission. However, since we were unable to rescue
the aldicarb hypersensitivity of the eat-6 mutants by expressing
EAT-6 in the ACh neurons, other experiments are necessary to
determine the mechanisms by which EAT-6 regulates presynaptic
neurotransmission.
The synaptic architecture of the eat-6(ad467) mutant
To probe for a possible role of eat-6 in synaptic architecture we
examined the expression and localization of GFP-tagged post- and
presynaptic markers in eat-6(ad467) animals. We found that UNC-
29::GFP fluorescence at the bodywall NMJs was slightly increased
in the ad467 animals relative to WT (Figure S4), although this
difference was not statistically significant. This result is in
agreement with a published study [8].
We also examined fluorescence of the GFP-tagged synaptic
vesicle marker synaptobrevin snb-1 expressed in a subset of the
cholinergic motor neurons under the unc-4 promoter [27]. No
significant difference in SNB-1::GFP fluorescence was found
between ad467 and WT worms (data not shown), which is again
consistent with the previous report [8]. These results indicate that
the eat-6(ad467) mutation does not cause any gross defect in
morphology of the NMJs.
To test whether hypersensitivity to aldicarb in the eat-6(ad467)
mutant is resulted from alterations in synaptic vesicle formation or
distribution, we carried out ultrastructural analysis of the ACh
synapses by transmission electron microscopy (TEM). We found
that the mean number of vesicles per synaptic profile was greater
Figure 4. eat-6 is expressed in muscles and neurons. (a) Photomicrographs of animals expressing GFP driven by the eat-6 promoter. (b) Top, a
photomicrograph of GFP driven by the eat-6 promoter; middle, a photomicrograph of mCherry driven by the unc-17 promoter; and bottom, merge of
the top and middle images.
doi:10.1371/journal.pone.0010368.g004
Figure 5. eat-6 in both muscles and neurons regulates synaptic
transmission. Synaptic transmission was assayed by scoring paralysis
induced by levamisole (a) or aldicarb (b) at concentrations indicated in
each panel. The relative reciprocal T50 values were calculated as
described in Figure 2a. The error bars indicate SEM (n.3 replicates).
*p ,0.05, ** p,0.001, compared to WT. Student’s t-test.
doi:10.1371/journal.pone.0010368.g005
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processes in the nerve ring and along the ventral cord show large
variations in axon diameter in correlation with vesicle content at
synapses. The axon plasma membrane at a synaptic site is molded
tightly around vesicle clusters, so the more vesicles, the larger the
axon caliber [28,29] (Hall, unpublished). Indeed, the mean area of
the axon profile at ACh synapses in eat-6 mutant animals is
significantly larger than that in WT (Figure 6d). This result
suggests that EAT-6 might play a role in regulation of the
abundance of synaptic vesicles at the NMJs. The reason for the
discrepancy between an increased number of synaptic vesicles
revealed by EM analyses and the insignificant change in GFP-
tagged synaptobrevin by fluorescence microscopy is not clear at
present. One possibility could be that subtle changes in intensity of
the GFP reporters may not be discernible with our experimental
setting. Another attractive hypothesis would be less synaptobrevin
per synaptic vesicle in eat-6 mutants.
EAT-6 acts upstream of EGL-30 Gaq in a genetic pathway
To gain more insights into molecular mechanisms by which
EAT-6 regulates synaptic transmission, we have sought for
mutations in other genes that might block aldicarb hypersensitivity
in the eat-6(ad467) mutant. Gaq EGL-30 promotes production of
diacylglycerol (DAG), which facilitates ACh release from the
ventral cord motor neurons [30,31]. The egl-30(ad806) loss-of-
function mutant animals are resistant to aldicarb [32]. We found
that egl-30(ad806) eliminated aldicarb hypersensitivity of ad467
(Figure 7a). The egl-8 phospholipase Cb is a downstream target of
egl-30 in the presynaptic pathway, and egl-8 loss-of-function
mutants show phenotypes similar, albeit weaker, to those of egl-
30 mutants [32,33]. The egl-8(n488)lf mutation also suppressed
hypersensitivity of the eat-6 mutant to aldicarb (Figure 7a). These
results suggest that eat-6 acts upstream of egl-30 in the genetic
pathway. egl-30 expression has been shown in neurons, pharyngeal
and vulval muscles, but not in the bodywall muscles [34].
Interestingly, the egl-30;eat-6 and egl-8;eat-6 double mutants
remained hypersensitive to levamisole (Figure S5).
There are no predicted voltage-gated Na
+ channels in the C.
elegans genome [35], and no Na
+ APs are generated in C. elegans
neurons [36]. Nevertheless, EAT-6 Na
+,K
+-ATPase may influence
neurotransmitter release from the motor neurons by changing the
resting membrane potential, and/or by influencing the activity of
other ion channels or transporters. To explore a possible role of
EAT-6 in this process, we analyzed the interaction between EAT-
6 and SLO-1. SLO-1 is a large-conductance, Ca
2+-activated K
+
channel that acts presynaptically to repolarize active neurons,
leading to closure of the voltage-gated Ca
2+ channels and thus
terminating neurotransmitter release [37]. Loss of slo-1 function
causes prolonged ACh release and hypersensitivity to aldicarb
[37]. Conversely, worms carrying the slo-1(ky399) gain-of-function
mutation are resistant to aldicarb [38], presumably because of a
shortened duration of ACh synaptic release. When we crossed the
Figure 6. The eat-6(ad467) mutant accumulates more synaptic vesicles at ACh NMJs. (a) and (b) Representative synaptic profiles of WT and
ad467 mutant worms obtained by high-pressure freezing EM. Arrows point to the active zone. (c) The average number of synaptic vesicles per profile
and SEM, * p,0.005. (d) The average area of the synaptic profile and SEM. ** p,0.001. The data were collected from 24 and 23 synaptic profiles,
respectively, in WT and ad467 worms. Four animals per each genotype were analyzed. Student’s t-test.
doi:10.1371/journal.pone.0010368.g006
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mutant remained as hypersensitive to aldicarb as the single eat-
6(ad467) mutant (Figure 7b), in contrast to the eat-6(ad467);egl-
30(ad806) double mutant that became resistant (Fig. 7a). This
result suggests that EAT-6 activity is required for the gain-of-
function effect of slo-1(ky399).
Although overexpression of eat-6 in the WT background caused
hypersensitivity to aldicarb as did the ad467 mutation (Figure 3a),
the slo-1(ky399);Ex[eat-6(+)] transgenic animals exhibited aldicarb
sensitivity similar to that of WT animals (Figure 7b), suggesting
that an excess of EAT-6 can compensate for or offset the effect of
the ky399 mutation. Similarly, the ky399 mutation also suppressed
aldicarb hypersensitivity induced by ACh::eat-6 (Figure 7b).
Therefore, although both reduction and excess of EAT-6 function
cause hypersensitivity to aldicarb, their mechanisms differ.
Exogenous 5-HT acts via egl-30, tom-1 and slo-1
Exogenous 5-HT inhibits the paralytic effects of aldicarb but
does not affect the sensitivity to levamisole (data not shown) [17],
suggesting that 5-HT regulates presynaptic ACh release. The
resistance to 5-HT treatment observed in ad467 and eat-6 RNAi
animals (Figures 2 and 3) could reflect a specific role of EAT-6 in
5-HT signaling or a general phenotype of aberrant synaptic
transmission. To discriminate between these possibilities, we
analyzed the effects of 5-HT on aldicarb-induced paralysis in
mutants defective in different aspects of ACh neurotransmission. It
has been reported that worms carrying egl-30 loss- or gain-of-
function mutations showed opposite egg-laying phenotypes, but
were both resistant to stimulation of egg laying by 5-HT treatment
[30]. Similarly, we found that although loss- and gain-of-function
egl-30 mutants were, respectively, resistant and hypersensitive to
aldicarb [32], they were both insensitive to 5-HT treatment
(Figure 8). Since aldicarb hypersensitivity of eat-6(ad467) worms
was suppressed by egl-30(ad806), but not by slo-1(ky399), we tested
whether 5-HT can modify aldicarb sensitivity in slo-1 mutants. We
found that both loss- and gain- of-function slo-1 mutants were
resistant to 5-HT treatment (Figure 8). Furthermore, mutants of
the syntaxin-binding protein TOM-1, which regulates synaptic
vesicle priming [39], were also resistant to 5-HT treatment
(Figure 8). We conclude that mutations that disrupt regulated
neurotransmitter release by either enhancing or attenuating it may
compromise the effects of 5-HT treatment. Interestingly, WT
animals expressing Ex[eat-6(+)] remained partially responsive to 5-
HT treatment (Figure 3a), indicating that excessive amounts of
normal EAT-6 protein does not disrupt 5-HT signaling. These
results support the notion that 5-HT acts via presynaptic
mechanisms to modulate synaptic transmission [17], and suggest
that EAT-6 is a component in the pathway regulated by 5-HT.
Deletion of the G protein-coupled 5-HT receptor SER-4
suppresses aldicarb hypersensitivity of eat-6 mutants
The C. elegans genome encodes one ionotropic 5-HT receptor
and seven predicted G protein-coupled 5-HT receptors [40]. To
identify receptors responsible for modulation of ACh neurotrans-
mission by exogenous 5-HT, we analyzed available deletion
mutants of these genes by the aldicarb assay. The sensitivity to
aldicarb itself was not significantly changed in any of the tested 5-
HT receptor mutants compared to that of WT (Figure 9a,c).
However, the functional null allele ser-4(ok512) [41] was
completely resistant to 5-HT treatment (Figure 9a). Transgenic
expression of WT ser-4 gene rescued 5-HT sensitivity of the ser-
Figure 7. Genetic interaction between eat-6 and egl-30, egl-8
and slo-1. Relative reciprocal T50 values of paralysis induced by aldicarb.
The error bars indicate SEM (n.3 replicates). * p,0.05, ** p,0.005,
compared to WT. The p value between two tested groups is indicated on
the top of the bars. In (a) the difference between egl-30(ad806) and
ad467;ad806 is significant (p,0.5). Student’s t test.
doi:10.1371/journal.pone.0010368.g007
Figure 8. Mutants of egl-30, tom-1 and slo-1 are insensitive to 5-
HT treatment. Relative reciprocal T50 values and SEM of aldicarb-
induced paralysis of worms pretreated with 5-HT (hatched bars) and
that without 5-HT treatment. The values of 5-HT-treated WT worms and
mutants are normalized to that of WT worms without 5-HT treatment.
n.3 replicates. None of the tested mutants showed significant
difference between 5-HT-treated and untreated worms, Student’s t test.
doi:10.1371/journal.pone.0010368.g008
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required for exogenous 5-HT to downregulate ACh neurotrans-
mission. To determine whether SER-4 acts in the ACh neurons,
we generated transgenic animals expressing ser-4 cDNA specifi-
cally in these neurons (ACh::ser-4) in the ok512 background. The 5-
HT response in such animals was fully restored (Figure 9a).
Deletion mutants of ser-1, ser-5, ser-7 and mod-1 also showed
reduced sensitivity to 5-HT treatment (Figure 9c), suggesting that
multiple 5-HT receptors are at work at the NMJs.
To elucidate the relationship between 5-HT signaling and EAT-
6, we generated an eat-6(ad467);ser-4(ok512) double mutant.
Surprisingly, although the ser-4(ok512) mutant itself showed WT
sensitivity to aldicarb, the ser-4 mutation significantly suppressed
aldicarb hypersensitivity of the eat-6(ad467) mutant (Figure 9b;
Figure S6). Likewise, null mutants of the tryptophan hydroxylase
gene tph-1 that cannot biosynthesize serotonin [42] showed WT
sensitivity to aldicarb, but the tph-1 mutation significantly
attenuated aldicarb hypersensitivity of the eat-6(ad467) mutant
(Figure 9b). These results indicate that there is indeed a genetic
interaction between eat-6 and endogenous 5-HT signaling.
Specific serotonergic neurons are responsible for
stimulatory and inhibitory 5-HT inputs
Suppression of aldicarb hypersensitivity of the eat-6(ad467) mutant
by the ser-4 mutation raises a possibility for a stimulatory 5-HT input
to ACh neurotransmission. Genetic analysis of C. elegans has
demonstrated that distinct serotonergic neurons regulate specific
aspects of behavior [43] and that multiple 5-HT receptors may exert
opposite effects on the same behavior [44]. To understand how
serotonergic neurons regulate ACh neurotransmission, we analyzed
the role of 5-HT signal from specific neurons. In C. elegans
hermaphrodites, 5-HT is primarily produced in the ADF chemosen-
sory neurons, the NSM secretory neurons in the head region, and the
HSN motor neurons responsible for egg laying [42,45]. In addition,
the single RIH neuron and a pair of the AIM interneurons can absorb
extracellular 5-HT via the serotonin reuptake transporter (SERT)
MOD-5, but cannot synthesize it (Kullyev et al., unpublished).
To test for contributions of specific serotonergic neurons in
modulation of neurotransmission, we expressed tph-1 cDNA either
in the ADF neurons or the NSM neurons in a tph-1 null
background. To prevent neurons from absorbing extracellular 5-
HT, we introduced individual neuron-specific tph-1 transgenes into
the tph-1;mod-5 double mutant. We confirmed the presence of 5-
HT in specific neurons by staining the transgenic animals with
anti-5-HT antibodies (data not shown). When the tph-1 transgene
was expressed in the ADF neurons in the tph-1;mod-5 background,
the worms became strongly hypersensitive to aldicarb (Figure 10).
Conversely, when 5-HT was excluded from the ADF neurons, but
present in the other neuronal classes, the worms were slightly
resistant to aldicarb, as compared to WT (Figure 10). A similar
degree of resistance was also observed in the TRPV channel ocr-2
mutants, which has reduced 5-HT specifically in the ADF neurons
[46]. These results indicate that endogenous 5-HT released from
the ADF neurons stimulates ACh synaptic transmission at the
NMJs, whereas 5-HT from the NSM/RIH/AIM neurons inhibits
the stimulatory 5-HT inputs.
Figure 9. Role of 5-HT receptors in response to exogenous 5-HT. (a) The response to 5-HT treatment of ser-4 mutants and the mutants
expressing a WT ser-4 transgene. Aldicarb-induced paralysis of worms pretreated with 5-HT (hatched bars) and those without 5-HT treatment (black
bars) were scored by calculating the percentage of worms paralyzed after 60 min of exposure to aldicarb. The error bars indicate SEM (n.3
replicates). Noticeably, the aldicarb sensitivity of ok512;Ex[ser-4(+)] #1 worms without 5-HT treatment is significantly (p,0.05) higher than that of WT.
(b) Mutations in ser-4 and tph-1 suppress aldicarb hypersensitivity of eat-6 mutant worms. Aldicarb-induced paralysis was scored after 100 min of
exposure to the drug. The error bars indicate SEM (n.3 replicates). (c) The response to 5-HT treatment of mutants of other 5-HT receptors. Aldicarb-
induced paralysis of worms pretreated with 5-HT (hatched bars) and that without 5-HT treatment was scored by calculating the percentage of worms
paralyzed after 60 min of exposure to the drug. The error bars indicate SEM (n.3 replicates). The values of 5-HT-treated WT worms and mutants are
normalized to that of WT worms without 5-HT treatment. Student’s t-test.
doi:10.1371/journal.pone.0010368.g009
Model FHM2 Synaptic Function
PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10368Discussion
FHM was the first human disease linked to mutations in a
specific subunit of Na
+,K
+-ATPase [47]. Later it became evident
that the same a2 subunit is associated with a much broader
spectrum of pathologies, including other forms of migraine,
epilepsy and ataxia [48]. In addition, mutations in the a3 subunit
have been found in patients suffering from rapid-onset dystonia
Parkinsonism [49]. Finally, genetic variations in all three subunits
of Na
+,K
+-ATPase expressed in brain have been linked to bipolar
disorders [50]. Cellular and molecular mechanisms by which
specific mutations cause disease phenotypes remain poorly
understood. In this study, we showed that EAT-6, a C. elegans
homolog of human FHM2, controls excitatory synaptic transmis-
sion and its modulation by 5-HT, both of which are altered in
migraine patients.
Both reduction and excess of EAT-6 Na
+,K
+-ATPase alter
synaptic transmission
There is an ongoing debate in the literature on whether FHM2
mutations cause pathology by a loss- or a gain-of function
mechanism [51]. Several FHM2 alleles have been studied by
expressing the mutant genes in oocytes or cell culture. Some of the
FHM2 mutations clearly result in reduced function of the enzyme,
ranging from a complete loss of pump current to subtle changes in
the voltage gating, cation affinities or enzyme turnover [52]. On
the other hand, certain effects of FHM2 mutations argue for gain-
of-function activity [51]. In this study, we found that both silencing
eat-6 by RNAi and eat-6 overexpression increased sensitivity to an
ACh esterase inhibitor, suggesting enhanced ACh neurotransmis-
sion. These findings may provide a clue to reconcile some
paradoxical observations of the pathogenic FHM2 alleles.
A primary cause of the migraine aura is ‘‘cortical spreading
depression’’ (CSD), a wave of transient neuronal depolarization
that spreads over the brain cortex and presumably activates the
trigeminovascular system resulting in migraine headache. Muta-
tions in all FHM genes have been predicted to cause increased
levels of the neurotransmitter glutamate and K
+ in the synaptic
cleft leading to increased propensity for CSD [53]. In the case of
FHM1 this hypothesis has been validated by analysis of knock-in
mice [54]. However, for FHM2 such studies have not yet been
reported. Our genetic analyses of EAT-6 supports a model that the
FHM2 Na
+,K
+-ATPase may regulate synaptic transmission both
pre- and postsynaptically.
What are the molecular mechanisms by which eat-6 mutations
may enhance ACh neurotransmission at the NMJ? A postsynaptic
role for eat-6 has been shown convincingly before by others [8].
Our ACh neuron-specific eat-6 RNAi results suggest that eat-6 may
also function in the ACh neurons to regulate neurotransmission.
We observed an increased number of synaptic vesicles in the eat-
6(ad467) mutant. Although the mechanism by which Na
+,K
+-
ATPase regulates the abundance of synaptic vesicles is unclear,
our genetic analyses shed some light on a possible role of EAT-6 in
regulation of ACh neurotransmission. The aldicarb hypersensitiv-
ity by reduced EAT-6 function could be, at least in part, ascribed
to exaggeration of EGL-30 Gaq signaling to the EGL-8
phospholipase, because a reduction of egl-30 and egl-8 function
suppressed aldicarb hypersensitivity of the eat-6(ad467) mutant.
Moreover, we found that a slo-1(gf) mutant overexpressing EAT-6
exhibited WT aldicarb sensitivity, although slo-1(gf);eat-6 double
mutant worms were as hypersensitive to aldicarb as the eat-6 single
mutant. These results suggest that, while both reduced and
excessive EAT-6 function may increase ACh neurotransmission,
their mechanisms differ. One possibility would be that the
hyperactivity of SLO-1 compensates for the effects caused by
increased EAT-6 function, whereas a reduced transmembrane K
+
gradient in eat-6 mutant animals renders this hyperactive SLO-1
channel inefficient. It has been reported that EAT-6 possesses a
novel function that is unrelated to the pump function of this
enzyme [8]. We speculate that overexpression and the mutation of
EAT-6 differentially affect this yet undefined EAT-6 function,
which in turn perturb particular aspects of cellular mechanisms in
ACh neurotransmission. However, since we were unable to rescue
the aldicarb hypersensitivity of the eat-6 mutants by expressing
EAT-6 in the ACh neurons, other experiments are necessary to
determine its role in regulation of presynaptic neurotransmission.
Opposing 5-HT inputs to ACh neurotransmission
We demonstrated that eat-6 not only regulates ACh neuro-
transmission, but it is also involved in modulation of this process
Figure 10. 5-HT from the ADF and the NSM/RIH/AIM neurons antagonistically regulates ACh neurotransmission. Relative reciprocal
T50 values of aldicarb-induced paralysis of worms expressing the tph-1 gene in specific neurons. The error bars indicate SEM (n.3 replicates).
*p ,0.05, ** p,0.005, compared to WT by Student’s t-test. The presence or absence of 5-HT in specific neurons is designated by ‘‘+’’ or ‘‘-’’,
respectively.
doi:10.1371/journal.pone.0010368.g010
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mutants as well as mutants of many synaptic components being
completely resistant to 5-HT treatment suggests that eat-6 is one
component mediating the inhibitory input of 5-HT to ACh
neurotransmission. This result could be relevant to the therapeutic
effects of drugs targeting 5-HT receptor subtypes in the treatment
of migraine [55].
Analysis of the G protein-coupled 5-HT receptor ser-4 revealed
dual stimulatory and inhibitory 5-HT inputs to ACh neurotrans-
mission. One the one hand, ser-4 appears to be the primary
receptor that mediates inhibition of ACh neurotransmission by
exogenous 5-HT. On the other hand, deletion of ser-4 significantly
suppressed aldicarb hypersensitivity of the eat-6(ad467) mutant,
suggesting that SER-4 activity is required for the increased
aldicarb sensitivity of the eat-6 mutant. Such dual activities of 5-
HT receptors have been observed in mammals. For example, the
5-HT1A receptor can both stimulate and inhibit adenylyl cyclase
[56]. Further experiments are required to discern the precise
mechanisms of SER-4 action in stimulatory and inhibitory 5-HT
signaling. One thought is that ser-4 may function in different
neurons to inhibit or stimulate ACh neurotransmission. In rodents,
in vivo binding assays showed that the 5-HT1A receptor expressed
in different neurons in the CNS has different affinities to 5-HT. It
is plausible that different levels of 5-HT differentially activate
SER-4 in different neurons to modulate ACh neurotransmission.
Consequently, the ser-4 mutation would abolish both the inhibitory
and stimulatory 5-HT inputs to ACh neurotransmission, while loss
of EAT-6 may selectively block the inhibitory 5-HT input.
Interestingly, we found that specific serotonergic neurons are
responsible for stimulatory and inhibitory 5-HT inputs to ACh
neurotransmission at the bodywall NMJs. Genetic analyses in C.
elegans have demonstrated that 5-HT released from specific
neurons regulates specific behavior [43], while many 5-HT
receptors synergistically or antagonistically regulate the same
behavior [41,44]. It may be sensible that different serotonergic
neurons regulate different receptor subtypes at different cellular
targets coordinating synaptic activity according to dynamic
changes in the environment.
Materials and Methods
Strains
C. elegans strains were maintained at 20uC as described [57].
Wild-type (WT) animals were the Bristol Strain N2. Mutants used
were: AQ279 unc-29(x29);Ex[unc-29::gfp;rol-6(d)], CX6741 tph-
1(mg280);Ex[ADF::tph-1], CX7749 tph-1(mg280);Ex[NSM::tph-1],
DA1239 eat-6(ad467);adEx1239[eat-6(+); rol-6(d)], eat-6(ad467),
eat-6(ad601), eat-6(ad792), eat-6(ad997), VC836 eat-6(ok1334)/
nT1[qIs51], egl-8(n488), egl-30(ad806), egl-30(tg26), mod-1(ok103),
mod-5(n3314), MT15434 tph-1(mg280), NM670 Ex[punc-4::snb-
1::gfp;lin-15(+)], ocr-2(yz5), rrf-3(pk1426), ser-1(ok345), ser-3(ok1995),
ser-3 (ok2007), ser-4(ok512), ser-5(tm2647), ser-5(tm2654), ser-
7(tm1325), slo-1(js379), slo-1(ky399), tom-1(ok285), unc-17(e245).
The following eat-6(ad467) double mutants were generated in
this study: eat-6(ad467);egl-30(ad806), eat-6(ad467);egl-8(n488), eat-
6(ad467);slo-1(ky399), eat-6(ad467);tph-1(mg280), eat-6(ad467);ser-
4(ok512), eat-6(ad467);nT1. In the case of the deletion alleles
n488, mg280 and ok512 that can be identified by PCR, we first
isolated homozygous ad467 based on its slow pharyngeal pumping,
small body size and fewer eggs (all these phenotypes manifest in
eat-6 RNAi worms), then isolated the homozygous deletion
mutations. In the case of the missense alleles ky399 and ad806,
we first isolated cross-progeny showing the phenotypes of the
homozygous ky399 (uncoordinated locomotion [38]), and egl-30
(sluggish movement and an increased number of eggs in the uterus
[30]), and then picked homozygous ad467 animals from their
progeny. To construct the ad467;nT1 strain, we generated males in
the ok1334;nT1 strain, which carries the homozygous ok1334
mutation maintained by a single copy of the nT1 translocation
marked by GFP. These males were crossed with ad467
hermaphrodites. The isolation of the homozygous ad467 progeny
carrying nT1 was based on two criteria: first, worms should not
carry the ok1334 deletion as determined by PCR; second, as the
strain carries a single copy of nT1, the progeny that do not carry
nT1 should show the ad467 phenotypes. All the missense alleles
were confirmed by sequencing.
RNAi experiments
The rrf-3 strain with enhanced neuronal sensitivity to RNA
interference [58] was used to silence eat-6, as described [59].
Briefly, NGM plates containing 6 mM IPTG were seeded with
bacterial cultures expressing the empty vector L4440 or eat-6
RNAi construct from the RNAi feeding library constructed by J.
Ahringer’s group at the University of Cambridge and incubated
overnight. 5–7 gravid rrf-3 hermaphrodites were allowed to lay
eggs on these plates for one day and removed afterwards. The
progeny on the plates were analyzed when they became adults
after three days.
Constructs and transgenes
All the constructs were generated by PCR, and purified PCR
fragments were used to generate transgenic animals. Unless
specified otherwise, pinx-16::gfp, which is expressed in the intestine
[60], was used as a transformation marker. The transcriptional
reporter peat-6::gfp was generated by fusion of 1548 bp upstream of
the translation start of eat-6, the same promoter element contained
in Ex[eat-6(+)] [10], with the sequence of GFP and UNC-54 39-
untranslated regulatory element (UTR) in the plasmid pPD95.75
(from A. Fire, Stanford University School of Medicine, Stanford,
CA). For tissue-specific expression full-length eat-6 cDNA was
amplified from RNA isolated from WT animals by RT-PCR
(SuperScript III First-Strand Synthesis System, Invitrogen) and
fused with unc-54 39 UTR and either the unc-17 [25] or myo-3 [61]
promoter. punc-17::mCherry was generated by fusion of the unc-17
promoter element with the sequence of mCherry and unc-54 39-
UTR. The Ex[ser-4(+)] transgene has been described previously
[41]. For cell-specific expression in ACh neurons full-length ser-4
cDNA amplified from WT RNA was fused with the unc-17
promoter and unc-54 39 UTR. The construction and character-
ization of the transgenes expressing tph-1 in the ADF (under the
srh-142 promoter) or NSM (under the ceh-2 promoter) neurons
have been described [43].
To knock down eat-6 expression specifically in ACh neurons, we
used a cell-specific RNAi approach [24]. Briefly, an eat-6 exon-rich
1089 bp genomic fragment, which was used to generate the eat-6
RNAi clone in the RNAi feeding library [59], was fused in the
forward and reverse orientations by two different PCR reactions
with the unc-17 promoter and unc-54 39 UTR, so that the eat-6
gene fragment can be transcribed by the unc-17 promoter in the
sense and antisense orientations. The two constructs were
coinjected into worms in equal concentrations (,100 ng/ml).
Fluorescence microscopy
GFP fluorescence was monitored using a 636 objective lens
with an AxioImager Z1 miscroscope (Zeiss). Images were captured
at 262 binning with an AxioCam MR digital camera using the
AxioVision software (Zeiss). The neutral density filter #5 of the
microscope was used to reduce the intensity of fluorescence
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(500 ms) was used for all samples. The ImageJ software (NIH) was
used for image analysis.
Drug-induced paralysis assays
Sensitivity to drugs was determined by scoring paralysis after
placing the animals on plates containing aldicarb or levamisole
(Sigma) at the concentrations indicated in the figures. L4 stage
animals were transferred to plates seeded with food and incubated
at 20uC overnight, and resultant young adults were analyzed. An
animal was scored as being paralyzed if no movement was
detected after prodding with a platinum wire. In all experiments
except that in Figure 9a,c, the time course of paralysis was
measured by scoring percentage of animals paralyzed on the plates
every 20 minutes over a three-hour period. To assay the inhibition
of aldicarb effects by serotonin, animals were first incubated for
2 h on plates containing 5 mg/ml of serotonin creatine sulfate
(Sigma), and were then transferred to plates containing both
aldicarb (1 mM) and serotonin (5 mg/ml), and the time course of
paralysis was assayed. For each genotype at least 3 independent
trials were carried out, each performed in duplicate with 10
animals per assay plate. The results of mutants were compared
with that of WT animals assayed in parallel.
Egg laying assay
Egg-laying behavior was evaluated by two well-established
methods (18, 41). In both cases L4 stage animals were picked onto
fresh plates seeded with food and allowed to develop at 20uC, and
one-day old adults were analyzed. To test the response to 5-HT,
animals were placed individually into wells of a 96-well plate, with
each well containing 100 ml of a solution (M9 buffer or M9 buffer
containing 5 mg/ml of serotonin). The number of eggs laid was
scored after 1 h. To score the number of eggs carried in the uterus,
individual one-day old adults were placed into a drop of solution
containing commercial bleach and 2N NaOH on a glass slide. The
bleach solution dissolved the body of the adult animal, and eggs,
which were protected by their eggshells, were scored immediately.
Eight animals per genotype for each condition were assayed in
each trial.
Extracellular EPG recording
Extracellular recording of the electrical activity of the pharynx
was made from intact worms as previously described [62]. One-
day old adult worms were incubated in M9 buffer containing
10 mM 5-HT to stimulate pharyngeal pumping. The signals were
acquired with an Axopatch 200B amplifier (Molecular Devices,
Sunnyvale, CA) in voltage-clamp mode at 10 kHz sampling rate
and were digitized using a Digidata 1322A AD/DA acquisition
system controlled by a PC running Clampex 10.0 software
(Molecular Devices), and analyzed using pClamp 10.0 software.
The EPG reflects the time derivative of the membrane potential of
the pharyngeal muscles. The EPG of WT worms consists of a large
positive E peak, corresponding to muscle excitation, a plateau
phase, and a large negative R spike, corresponding to muscle
repolarization. In addition, recording EPG allows us to monitor
neuronal inputs to the muscles. In particular, a small positive peak
preceding the E peak represents an excitatory post-synaptic
potential (EPSP) [21]. It results from activation of nicotinic
receptors in the muscle membrane by ACh released from the MC
neuron [63]. The amplitudes of the E and R spikes were measured
in each of the first 5 action potentials recorded from each of 15–20
worms per genotype. Data collected from each individual worm
were pooled together, and the mean R/E ratio was calculated for
each genotype. To determine the percentage of the failed EPSPs,
recording has been done till at least 30 action potentials were
generated. All but the last EPSP in the series were counted, and
those that were not immediately followed by the E spike were
considered failed.
EM analysis
For transmission EM one-day old adult animals were fixed by
high-pressure freezing and freeze-substitution, using 2% osmium
tetroxide in acetone as the primary fixative [64]. Serial sections
(80 nm thickness) of fixed animals were collected on copper slot
grids and stained with 4% uranyl acetate in 70% methanol,
followed by washing and incubating with lead citrate. Images were
captured using a Philips CM10 transmission electron microscope
at 80 kV equipped with a Morada 11 MPixel TEM CCD camera
driven by the iTEM software (Olympus Soft Imaging Solutions). A
set of serial sections containing a presynaptic density was defined
as a synapse, and the number of vesicles per synaptic profile was
calculated in the middle section of each set using NIH ImageJ
software. Neuronal classes (VA or VB, both cholinergic; or VD,
GABAergic) were identified by tracing the processes along the
anterior ventral cord in a series of about 500 serial sections per
animal [65].
Statistical analyses
Statistical analyses were performed using Origin 7.0 software
(OriginLab Corporation, Northampton, MA). Significance was
tested using an unpaired two sample Student’s t test. Throughout
the article data are expressed as mean 6 SEM.
Supporting Information
Figure S1 A single copy of the genomic eat-6 gene rescues the
aldicarb hypersensitivity of the eat-6(ad467) mutant. Relative
reciprocal T50 values of aldicarb-induced paralysis of worms with
different ratios of WT to mutant eat-6 gene. An extra copy of the
eat-6(+) locus was introduced by the nT1 translocation into the eat-6
(ok1334) deletion background or into the eat-6(ad467) background.
Heterozygous ad467 animals were included as a control. The
genotypes of the tested strains are schematically represented at left.
The chromosomes IV and V are shown as long black and white
bars, respectively. A short black bar represents the WT eat-6 gene,
the horizontally hatched short bar: the eat-6(ad467) allele, and the
white short bar: the eat-6(ok1334) allele. The short obliquely
hatched bar represents the gfp marker. The error bars indicate
SEM (n.3 replicates).
Found at: doi:10.1371/journal.pone.0010368.s001 (0.48 MB TIF)
Figure S2 Expression of eat-6 cDNA in ACh neurons or body-
wall muscles does not rescue the aldicarb hypersensitivity of eat-6
mutants. Relative reciprocal T50 values of aldicarb-induced
paralysis of worms pretreated with 5-HT (hatched bars) and those
without 5-HT treatment (black bars). The values of 5-HT-treated
WT worms and mutants are normalized to that of WT worms
without 5-HT treatment. The error bars indicate SEM (n.3
replicates).
Found at: doi:10.1371/journal.pone.0010368.s002 (0.21 MB TIF)
Figure S3 Time courses of aldicarb-induced paralysis of the unc-
17(e245) and unc-17(e245);ACh::eat-6 transgenic animals. The error
bars indicate SEM (n=3 replicates).
Found at: doi:10.1371/journal.pone.0010368.s003 (0.15 MB TIF)
Figure S4 Intensity of UNC-29::GFP fluorescence in eat-
6(ad467) background, as compared to WT. Measurements were
performed in 18 ad467 and 47 WT worms. In each worm, an
anterior section of the ventral cord (,100 mm length) was
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calculated from profiles drawn across the middle of the puncta
along the ventral cord of individual worms. The error bars
indicate SEM between worms.
Found at: doi:10.1371/journal.pone.0010368.s004 (0.36 MB TIF)
Figure S5 Mutations in egl-30 or egl-8 do not suppress
hypersensitivity of the eat-6(ad467) worms to levamisole. Relative
reciprocal T50 values of paralysis were calculated as shown in
Fig. 2. The error bars indicate SEM (n.3 replicates). * p,0.05,
** p,0.005, compared to WT.
Found at: doi:10.1371/journal.pone.0010368.s005 (0.41 MB TIF)
Figure S6 Time courses of aldicarb-induced paralysis of eat-6
and eat-6;ser-4 mutants on1 mM (a) and 0.25 (b) mM aldicarb. The
difference between the two hypersensitive strains, which is not
significant on 1 mM of the drug, is clearly resolved on the lower
concentration. The error bars indicate SEM (n.3 replicates).
Found at: doi:10.1371/journal.pone.0010368.s006 (0.30 MB TIF)
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